Clayton, N.C.
Novo Nordisk broke ground in March of 2016 on a $1.8 billion pharmaceutical manufacturing plant in Clayton, N.C. Built by Fluor Corporation, the 833,000-sf facility will produce active pharmaceutical ingredients for diabetes treatments and will accommodate 700 employees. Construction is slated for completion in 2019 with full operations commencing in 2021. Novo Nordisk is based in Bagsvaerd, Denmark.
Source
